Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 5
2011 3
2012 4
2013 6
2014 5
2015 4
2016 5
2017 3
2018 5
2019 8
2020 8
2021 5
2022 2
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
13 C-depleted algae as food: Permitting background free in-vivo nuclear magnetic resonance of Daphnia magna at natural abundance.
Wolff WW, Pellizzari J, Soong R, Lysak DH, Steiner K, Ronda K, Costa P, Downey K, Moxley-Paquette V, Suszczynski C, Boehmer S, Prat JR, Simpson AJ. Wolff WW, et al. Among authors: lysak dh. Magn Reson Chem. 2024 Jan;62(1):11-18. doi: 10.1002/mrc.5409. Epub 2023 Nov 20. Magn Reson Chem. 2024. PMID: 37984890 No abstract available.
Low-field, not low quality: 1D simplification, selective detection, and heteronuclear 2D experiments for improving low-field NMR spectroscopy of environmental and biological samples.
Downey K, Bermel W, Soong R, Lysak DH, Ronda K, Steiner K, Costa PM, Wolff WW, Decker V, Busse F, Goerling B, Haber A, Simpson MJ, Simpson AJ. Downey K, et al. Among authors: lysak dh. Magn Reson Chem. 2024 May;62(5):345-360. doi: 10.1002/mrc.5401. Epub 2023 Oct 9. Magn Reson Chem. 2024. PMID: 37811556
Development of Low-Magnetic Susceptibility Microcoils via 5-Axis Machining for Analysis of Biological and Environmental Samples.
Moxley-Paquette V, Lane D, Steiner K, Downey K, Costa PM, Lysak DH, Ronda K, Soong R, Zverev D, De Castro P, Frei T, Stuessi J, Al Adwan-Stojilkovic D, Graf S, Gloor S, Schmidig D, Kuemmerle R, Kuehn T, Busse F, Utz M, Lacerda A, Nashman B, Albert L, Anders J, Simpson AJ. Moxley-Paquette V, et al. Among authors: lysak dh. Anal Chem. 2023 Sep 19;95(37):13932-13940. doi: 10.1021/acs.analchem.3c02437. Epub 2023 Sep 7. Anal Chem. 2023. PMID: 37676066
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Špaček M, Smolej L, Šimkovič M, Nekvindová L, Křístková Z, Brychtová Y, Panovská A, Mašlejová S, Bezděková L, Écsiová D, Vodárek P, Zuchnická J, Mihályová J, Urbanová R, Turcsányi P, Lysák D, Novák J, Brejcha M, Líkařová T, Vodička P, Baranová J, Trněný M, Doubek M; Czech CLL Study Group. Špaček M, et al. Among authors: lysak d. Br J Haematol. 2023 Jul;202(1):40-47. doi: 10.1111/bjh.18736. Epub 2023 Mar 27. Br J Haematol. 2023. PMID: 36971061
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Holicek P, Truxova I, Rakova J, Salek C, Hensler M, Kovar M, Reinis M, Mikyskova R, Pasulka J, Vosahlikova S, Remesova H, Valentova I, Lysak D, Holubova M, Kaspar P, Prochazka J, Kasikova L, Spisek R, Galluzzi L, Fucikova J. Holicek P, et al. Among authors: lysak d. Cell Death Dis. 2023 Mar 24;14(3):209. doi: 10.1038/s41419-023-05728-w. Cell Death Dis. 2023. PMID: 36964168 Free PMC article.
69 results